SINGAPORE - Patients with liver failure could in future have a stopgap treatment, which slows down or even reverses disease progression, while waiting for a liver transplant.
The treatment involves injection of healthy liver cells created from human embryonic stem cells.
Already a subscriber? Log in
Read the full story and more at $9.90/month
Get exclusive reports and insights with more than 500 subscriber-only articles every month
ST One Digital
$9.90/month
No contract
ST app access on 1 mobile device
Unlock these benefits
All subscriber-only content on ST app and straitstimes.com
Easy access any time via ST app on 1 mobile device
E-paper with 2-week archive so you won't miss out on content that matters to you
